# NOV — NOV · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** NOV  
**Sources:** 22  
**Published:** 2026-09-29  
**Canonical:** https://app.k3vl4r.com/research/deep-research-nov-nov-catalysts-narrative-risks-5210

---

## NOV Inc. (NYSE: NOV) — Research Snapshot as of 2026-09-29

### Recent Catalysts (July–September 2026)

**Q2 2026 earnings (released July 29, 2026)** is the dominant recent catalyst. NOV delivered adjusted EPS of $0.31 versus a $0.17 consensus forecast, beating estimates, while revenue of $2.13B was roughly in line with the ~$2.08B–$2.13B consensus and down 2.0% year-over-year but up 4% sequentially [[1]](https://news.alphastreet.com/nov-releases-q2-2026-financial-results/)[[7]](https://stockanalysis.com/stocks/nov/). Adjusted EBITDA was $283M, including a $40M tariff benefit, and net income was $112M [[1]](https://news.alphastreet.com/nov-releases-q2-2026-financial-results/)[[7]](https://stockanalysis.com/stocks/nov/). Book-to-bill was a strong +74%, and the Energy Equipment segment led with $1.22B in revenue (up 0.9% YoY) on a $4.08B energy-equipment backlog [[1]](https://news.alphastreet.com/nov-releases-q2-2026-financial-results/). Analyst commentary framed results as reflecting "significantly improved underlying industry fundamentals" [[7]](https://stockanalysis.com/stocks/nov/).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-nov-nov-catalysts-narrative-risks-5210 (free to sign up)._
